Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Instituto de Salud Carlos III
Madrid, EspañaPublications in collaboration with researchers from Instituto de Salud Carlos III (380)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Analysis of the Association between Copy Number Variation and Ventricular Fibrillation in ST-Elevation Acute Myocardial Infarction
International Journal of Molecular Sciences, Vol. 25, Núm. 5
-
Biallelic Loss of Function Variants in Myocardial Zonula Adherens Protein Gene (MYZAP) Cause a Severe Recessive Form of Dilated Cardiomyopathy
Circulation: Heart Failure
-
Ccn2 Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice
International Journal of Molecular Sciences, Vol. 25, Núm. 17
-
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy
Journal of the American Heart Association, Vol. 13, Núm. 21, pp. e036208
-
Clinical Relevance of the Systematic Analysis of Copy Number Variants in the Genetic Study of Cardiomyopathies
Genes, Vol. 15, Núm. 6
-
Connective tissue amyloidosis in patients referred for orthopedic surgery. CONNECT-AMY study
Medicina Clinica, Vol. 163, Núm. 8, pp. e84-e88
-
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
Nefrologia, Vol. 44, Núm. 5, pp. 709-720
-
Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies - opportunities and open questions. Response
Revista Espanola de Cardiologia
-
Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis
Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 667-679
-
Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 347-349
-
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
Journal of Cardiac Failure
-
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
European Journal of Heart Failure
-
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1821-1831
-
Impact of commissural alignment on the hemodynamic performance of supra-annular self-expandable transcatheter aortic valves
Catheterization and Cardiovascular Interventions, Vol. 104, Núm. 5, pp. 1060-1070
-
Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7
-
Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers
Journal of Medical Genetics, Vol. 61, Núm. 5, pp. 423-427
-
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry
Annals of the Rheumatic Diseases, Vol. 83, Núm. 9, pp. 1189-1199
-
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure
American Heart Journal, Vol. 267, pp. 52-61
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2